Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- New Haven, Connecticut
- Most recent report
- 8-K, filed Nov 6, 2026
- Incorporated
- Delaware
- Filings on record
- 310 filings
- On EDGAR
- CIK 1739410
- Fiscal year ends
- December
- Filer status
- Emerging growth company
Financials 8 of 22
News 8 of 52
Prospectuses and Registrations 8 of 24
- 424B3 Prospectus supplement for an offering Oct 15, 2026
- S-4/A Registration statement for a merger or exchange, amended Oct 14, 2026
- S-4/A Registration statement for a merger or exchange, amended Oct 5, 2026
- S-4/A Registration statement for a merger or exchange, amended Sep 16, 2026
- S-4/A Registration statement for a merger or exchange, amended Aug 26, 2026
- S-4 Registration statement for a merger or exchange Jul 15, 2026
- S-4/A Registration statement for a merger or exchange, amended Apr 24, 2026
- S-4 Registration statement for a merger or exchange Mar 17, 2026
Proxies 6
- DEF 14A Proxy statement for a shareholder vote Jan 2, 2026
- PRE 14A Preliminary proxy statement Dec 23, 2025
- DEF 14A Proxy statement for a shareholder vote Apr 7, 2025
- DEF 14A Proxy statement for a shareholder vote Apr 11, 2024
- DEF 14A Proxy statement for a shareholder vote Apr 10, 2023
- DEF 14A Proxy statement for a shareholder vote Apr 25, 2022
Ownership 8 of 174
- 4 Insider reported a trade Nov 5, 2026
- 4 Insider reported a trade Nov 5, 2026
- 4 Insider reported a trade Nov 3, 2026
- 4 Insider reported a trade Nov 2, 2026
- 4 Insider reported a trade Nov 2, 2026
- 4 Insider reported a trade Oct 30, 2026
- 4 Insider reported a trade Oct 29, 2026
- 4 Insider reported a trade Oct 28, 2026
Other 8 of 32
Everything here comes from Rallybio Corp's own filings on SEC EDGAR. The filing list is rechecked every hour.